Trials / Unknown
UnknownNCT02902094
Drug Eluting Balloon Venoplasty in AV Fistula Stenosis
Improving Outcomes in Fistula Intervention: A Prospective, Patient Blinded, Phase 3, Randomised Controlled Trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 186 (estimated)
- Sponsor
- University Hospital Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
DeVA is a single blinded, prospective, multicentre RCT designed to determine the safety and effectiveness of a drug eluting angioplasty balloon compared with a standard angioplasty balloon in patients with symptomatic native AV fistula stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug eluting balloons | |
| DEVICE | Non drug eluting balloons |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2016-09-15
- Last updated
- 2016-09-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02902094. Inclusion in this directory is not an endorsement.